Management of occult GI bleeding : a clinical guide / / Micheal Tadros, George Y. Wu, editors |
Edizione | [1st ed. 2021.] |
Pubbl/distr/stampa | Cham, Switzerland : , : Humana Press, , [2021] |
Descrizione fisica | 1 online resource (XV, 285 p. 124 illus., 97 illus. in color.) |
Disciplina | 616.33 |
Collana | Clinical gastroenterology (Series) |
Soggetto topico |
Gastrointestinal hemorrhage
Hemorràgia gastrointestinal Terapèutica |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-71468-3 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | An Introduction to the Clinical Approach and Management of Occult Gastrointestinal Bleeding -- Non-Invasive Office Screening Methods -- Endoscopic Detection -- Radiologic Detection -- Esophagus -- Etiologies of Occult Gastroduodenum Bleeding -- Occult Small Bowel Bleeding -- Occult Lower GI Bleeding -- Occult GI Bleeding: The Biliary-Pancreatic System -- Bipolar and Monopolar Cautery, Clips, Bands, Spray, Injections, Embolization, and Minimally Invasive Surgery -- Pediatrics -- Premenopausal Women -- Occult GI Bleeding: Considerations in Older Adults -- Gastrointestinal Bleeding in Native Cardiovascular Disease and Implantable Cardiac Devices -- NSAIDs/Anticoagulation -- Genetic Causes of Occult Gastrointestinal Bleeding. |
Record Nr. | UNINA-9910484575403321 |
Cham, Switzerland : , : Humana Press, , [2021] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Pocket handbook of GI pharmacotherapeutics / / edited by Achilles Pappano, George Y. Wu |
Edizione | [3rd ed.] |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (276 pages) |
Disciplina | 610 |
Collana | Clinical Gastroenterology |
Soggetto topico |
Medicine
Toxicology Gastroenterology Quimioteràpia Gastroenterologia |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-72592-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Preface -- Relative Cost -- Contents -- Contributors -- 1: Gastroesophageal Disorders -- Meclizine -- Dimenhydrinate -- Ondansetron -- Scopolamine Patch -- Gastroesophageal Reflux Disorder (GERD) and Peptic Ulcer Disease (PUD) -- Proton Pump Inhibitors (PPI) -- Omeprazole -- Esomeprazole Magnesium (Oral) -- Esomeprazole Sodium (IV) -- Lansoprazole -- Pantoprazole Sodium Oral and IV -- Rabeprazole Sodium -- Dexlansoprazole -- Histamine H2 Antagonists -- Famotidine -- Other Agents -- Sucralfate -- Suggested Reading -- 2: Gastrointestinal Bleeding -- Pantoprazole -- Esomeprazole -- Octreotide Acetate -- Vasopressin -- Metoclopramide -- Erythromycin -- Epinephrine -- Hemostatic Nanopowder -- Suggested Reading -- 3: Specific Gastrointestinal Motility Disorders -- Nifedipine -- Botulinum Toxin (Onabotulinum Toxin A) -- Isosorbide Dinitrate -- Gastroparesis -- Erythromycin -- Metoclopramide -- Azithromycin -- Prucalopride -- Domperidone -- Dumping Syndrome and Accelerated Gastric Emptying -- Octreotide -- Dexlansoprazole -- Rapid Transit Dysmotility of the Small Bowel -- Loperamide -- Suggested Reading -- 4: General Gastrointestinal Motility Disorders -- Diarrhea -- Dicyclomine Hydrochloride -- Hyoscyamine Sulfate -- Diphenoxylate Hydrochloride/Atropine Sulfate -- Loperamide -- Cholestyramine -- Imipramine -- Amitriptyline -- Constipation -- Psyllium -- Methylcellulose -- Docusate -- Magnesium Citrate -- Mineral Oil -- Polyethylene Glycol -- Lactulose -- Senna -- Bisacodyl -- Castor Oil -- Lubiprostone -- Linaclotide -- Plecanatide -- Prucalopride -- Irritable Bowel Syndrome-Diarrhea Predominant (IBS-D) -- Rifaximin -- Alosetron -- Eluxadoline -- Irritable Bowel Syndrome-Constipation Predominant (IBS-C) -- Tegaserod -- Tenapanor -- Suggested Reading -- 5: Inflammatory Bowel Disease -- Sulfasalazine -- Mesalamine -- Olsalazine -- Balsalazide.
Glucocorticoids: Prednisone, Methylprednisolone and Hydrocortisone -- Budesonide -- Hydrocortisone Retention Enema -- 6-Mercaptopurine (6-MP) -- Azathioprine -- Methotrexate (MTX) -- Cyclosporine -- Infliximab -- Adalimumab -- Certolizumab Pegol -- Golimumab -- Natalizumab -- Vedolizumab -- Ustekinumab -- Tofacitinib -- Suggested Monitoring for IBD Drugs -- Suggested Reading -- 6: General Gastrointestinal Infections -- Treatment of Acute Diverticulitis -- Cefotaxime -- Ceftriaxone -- Cefepime -- Metronidazole -- Levofloxacin -- Ciprofloxacin -- Sulfamethoxazole and Trimethoprim -- Piperacillin-Tazobactam -- Ertapenem -- Infective Endocarditis Prophylaxis for GI Procedures -- Suggested Reading -- 7: Specific Gastrointestinal Microbial Infections -- Clostridioides (formerly Clostridium) difficile Pseudomembranous Colitis -- Vancomycin -- Fidaxomicin -- Metronidazole -- Helicobacter pylori -- Amoxicillin -- Bismuth Subsalicylate -- Clarithromycin -- Levofloxacin -- Tinidazole -- E. coli (EP and EI) Gastroenteritis -- Shigella Colitis -- Salmonella Gastroenteritis -- Campylobacter Gastroenteritis -- Vibrio cholerae -- Yersinia Gastroenteritis -- Listeria monocytogenes -- Trimethoprim-Sulfamethoxazole -- Ciprofloxacin -- Whipple Disease -- Azithromycin -- Erythromycin -- Doxycycline -- Tetracycline -- Fungal Infections -- Fluconazole -- Voriconazole -- Caspofungin -- Clotrimazole -- Cryptosporidium hominis -- Cyclospora cayetanensis -- Nitazoxanide -- Viral Infections -- Ganciclovir -- Valganciclovir -- Foscarnet -- Protozoan Infections -- Amebiasis -- Giardiasis -- Parasitic Infestations -- Ascariasis (A. lumbricoides) -- Cutaneous Larva Migrans -- Cysticercosis (Taenia solium) -- Dracunculiasis (Guinea Worm Disease) -- Echinococcosis (Hydatid Cyst) -- Enterobiasis (Pinworm) -- Hook Worm (Ancylostomiasis). Lymphatic Filariasis (W. bancrofti, B. malayi, B. timori) -- Loaisis (M. streptocerca, O. volvulus, D. medinensis) -- Tropical Pulmonary Eosinophilia -- Trypanosoma cruzi (Chagas Disease) -- Onchocerciasis (River Blindness) -- Fluke Infections -- Schistosomiasis -- Strongyloidiasis -- Tapeworm Intestinal Infections (Taenia saginata) -- Trichinellosis (Roundworm) -- Trichuriasis (Whipworm) -- Albendazole -- Mebendazole -- Ivermectin -- Praziquantel -- Thiabendazole: No Longer Available in the USA -- Pyrantel Pamoate -- Tinidazole -- Paromomycin -- Iodoquinol -- Diethylcarbamazine -- Benznidazole -- Triclabendazole -- Suggested Reading -- 8: Hepatitis -- Chronic Hepatitis B -- Entecavir -- Tenofovir Dipovoxil Fumarate (TDF) -- Tenofovir Alafenamide (TAF) -- Pegylated Interferon α-2a -- Dosage Adjustments for PEG-Interferon α-2a (Pegasys) -- Pegylated Interferon α-2b -- Dosage adjustments for PEG-interferon α-2b: -- Lamivudine -- Adefovir Dipivoxil -- Chronic Hepatitis C -- Sofosbuvir -- Ledipasvir/Sofosbuvir -- Glecaprevir/Pibrentasvir -- Elbasvir/Grazoprevir -- Sofosbuvir/Velpatasvir/Voxilaprevir -- Daclatasvir -- Ribavirin -- Ribavirin Dosage Adjustments -- Pegylated Interferon α-2a -- Autoimmune Hepatitis -- Azathioprine -- Prednisone -- Budesonide -- Mycophenylate Mofetil (MMF) -- Alcoholic Hepatitis -- Prednisolone -- Suggested Reading -- 9: Portal Hypertension -- Nadolol -- Propranolol -- Carvedilol -- Suggested Reading -- 10: Cholestasis -- Primary Biliary Cholangitis (PBC) -- Ursodiol, Ursodeoxycholic Acid (UDCA) -- Obeticholic Acid (OCA) -- Primary Sclerosing Cholangitis (PSC) -- UDCA -- Suggested Reading -- 11: Hepatic Encephalopathy -- Lactulose -- Neomycin -- Rifaximin -- Suggested Reading -- 12: Ascites -- Ascites Management -- Furosemide -- Spironolactone -- Spontaneous Bacterial Peritonitis (SBP) -- Cefotaxime -- Ofloxacin -- Ceftriaxone. Norfloxacin -- Trimethoprim-Sulfamethoxazole -- Albumin -- Suggested Reading -- 13: Overload Disorders -- Hereditary Hemochromatosis -- Deferoxamine -- Deferasirox -- Wilson's Disease -- Penicillamine -- Trientine -- Tetrathiomolybdate -- Zinc Sulfate -- Gaucher's Disease -- Imiglucerase (Glucocerebrosidase) -- Velaglucerase Alfa (Glucocerebrosidase) -- Taliglucerase Alfa -- Miglustat -- Eliglustat -- Suggested Reading -- 14: Pruritus -- Diphenhydramine -- Hydroxyzine -- Cholestyramine -- Rifampin -- Ursodeoxycholic Acid -- Naltrexone -- Sertraline -- Suggested Reading -- 15: Post-Liver Transplant -- Immunosuppressant Drugs -- Glucocorticoids -- Tacrolimus -- Cyclosporine -- Azathioprine -- Mycophenolate Mofetil -- Sirolimus -- Everolimus -- Infection Prophylaxis Agents -- Antifungal Prophylaxis -- PCP Prophylaxis -- Antiviral Prophylaxis -- Suggested Reading -- 16: Acute and Chronic Pancreatitis Pain Syndromes -- Tramadol -- Renal Insufficiency -- Hepatic Impairment -- Hydromorphone -- Gabapentin -- Amitriptyline -- Duloxetine -- Octreotide -- Celiac/Splanchnic Nerve Block -- Suggested Reading -- 17: Pancreatic Insufficiency -- Pancrelipase -- Suggested Reading -- 18: Gut Malabsorption and Enzyme Deficiencies -- Lactase Deficiency -- Lactase -- Vitamin B12 Deficiency/Pernicious Anemia -- Vitamin B12 (Cyanocobalamin) -- Vitamin B12 Deficiency -- Pernicious Anemia -- Small Intestinal Bacterial Overgrowth (SIBO) -- Non-absorbable Antibiotics -- Systemic Antibiotics -- Neomycin -- Short Bowel Syndrome (SBS) -- Antisecretory Agents -- Antimotility Agents -- Codeine -- Tincture of Opium -- Bile Acid Binders -- Intestinotrophic Factors -- Suggested Reading -- Appendix A: Pregnancy and Lactation Labeling Rule -- Appendix B: Abbreviations -- Index. |
Record Nr. | UNINA-9910492146903321 |
Cham, Switzerland : , : Springer, , [2021] | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|